Currently out of the existing stock ratings of Dan Leonard, 99 are a HOLD (31.63%), 198 are a BUY (63.26%), 16 are a SELL (5.11%).

Dan Leonard

Work Performance Price Targets & Ratings Chart

Analyst Dan Leonard, carries an average stock price target met ratio of 71.1% that have a potential upside of 19.83% achieved within 216 days. Previously, Dan Leonard worked at UBS.

Dan Leonard’s has documented 654 price targets and ratings displayed on 42 stocks. The coverage was on Healthcare, Basic Materials, Industrials sectors.

Most recent stock forecast was given on WAT, Waters at 10-Feb-2026.

Wall Street Analyst Dan Leonard

Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for LMNX (LUMINEX) at 5/7/2018. The price target of $22 was fulfilled within 1 day with a profit of $0.64 (3%) receiving and performance score of 29.96.

Average potential price target upside

of $117.12 (10.84%) on MTD (METTLER-TOLEDO INTERNATIONAL).
of $51.26 (14.85%) on BIO (BIO-RAD LABORATORIES).
of $48.1 (29.94%) on LH (LABORATORY OF AMERICA HOLDINGS).

A Agilent Technologies AVTR Avantor BIO Bio-Rad Laboratories BRKR Bruker DHR Danaher EXAS EXACT Sciences GH Guardant Health HOLX Hologic ILMN Illumina IQV IQVIA Holdings MTD Mettler-Toledo International MYGN Myriad Genetics NTRA Natera NVTA Invitae Corp PKI PerkinElmer TECH Bio-Techne Corp TMO Thermo Fisher Scientific LH Laboratory of America Holdings WAT Waters CRL Charles River Laboratories DGX Quest Diagnostics FLDM Fluidigm ICLR ICON PLC QGEN Qiagen NV CERT Certara FLGT Fulgent Genetics MRVI Maravai Lifesciences Holdings STVN Stevanato Group SpA ADPT Adaptive Biotechnologies Corp PROG Progenity LMNX Luminex RHP Ryman Hospitality Properties GHDX Genomic Health CYRX Cryoport TXG 10X Genomics LAB Standard Biotools ALR Alerislife CDNA Caredx HTGM HTG Molecular Diagnostics MEDP Medpace Holdings VCYT Veracyte WST West Pharmaceutical Services

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Luke Sergott (BARCLAYS)